Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight

globenewswire.com
AZN Mentioned as a key company in the cervical cancer diagnostics market, but no specific details on its performance or outlook are provided. PBYI Included as a key company in the cervical cancer diagnostics market, without specific performance indicators or outlook. IOVA Mentioned as a key company in the cervical cancer diagnostics market and in clinical trials, but without specific performance details. REGN Listed as a key company in the cervical cancer diagnostics market and in clinical trials, with no specific performance analysis provided. BMY Mentioned as a key company in the cervical cancer diagnostics market and clinical trials, without specific performance details. MRK Listed as a key company in the cervical cancer diagnostics market and HPV vaccines market, with no specific performance analysis. AMGN Mentioned as a key company in the cervical cancer diagnostics market, but no specific details on its performance or outlook are provided. BDX Mentioned as a key company in the HPV testing and Pap test market, without specific performance indicators or outlook. QGEN Listed as a key company in the HPV testing and Pap test market, with no specific performance analysis provided. ABT Mentioned as a key company in the HPV testing and Pap test market, without specific performance indicators or outlook. DHR Listed as a key company in the HPV testing and Pap test market, with no specific performance analysis provided. BIO Listed as a key company in the HPV testing and Pap test market, with no specific performance analysis provided. TMO Mentioned as a key company in the HPV testing and Pap test market, without specific performance indicators or outlook. FMS Listed as a key company in the HPV testing and Pap test market, with no specific performance analysis provided. DXC Listed as a key company in the HPV testing and Pap test market, with no specific performance analysis provided. NVDA Listed as a key company in the AI in Cancer Diagnostics market, with no specific performance analysis provided. IBM Mentioned as a key company in the AI in Cancer Diagnostics market, without specific performance indicators or outlook. GEHC Listed as a key company in the AI in Cancer Diagnostics market, with no specific performance analysis provided. AI Mentioned as a key company in the AI in Cancer Diagnostics market, without specific performance indicators or outlook.

Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight New York, USA, May 14, 2026 (GLOBE NEWSWIRE) -- Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight

The cervical cancer diagnostics market is witnessing significant growth due to the rising prevalence of cervical cancer and increasing awareness regarding early screening and diagnosis. Growing adoption of advanced diagnostic technologies such as HPV testing, liquid-based cytology, and AI-powered screening tools is further accelerating market expansion. Government initiatives and large-scale screening programs, especially in emerging economies, are improving access to cervical cancer diagnostics.

DelveInsight’s Cervical Cancer Diagnostics Market Insights report provides the current and forecast market analysis, individual leading cervical cancer diagnostics companies’ market shares, challenges, cervical cancer diagnostics market drivers, barriers, trends, and key cervical cancer diagnostics companies in the market.

Cervical Cancer Diagnostics Market Summary

To read more about the latest highlights related to the cervical cancer diagnostics market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/cervical-cancer-diagnostics-market

Key Factors Contributing to the Rise in Growth of the Cervical Cancer Diagnostics Market

Get a sneak peek at the cervical cancer diagnostics market dynamics @ Cervical Cancer Diagnostics Market Trends

Regional Cervical Cancer Diagnostics Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the cervical cancer diagnostics market, get a snapshot of the Cervical Cancer Diagnostics Market Share

Recent Developmental Activities in the Cervical Cancer Diagnostics Market

What are Cervical Cancer Diagnostics?

Cervical Cancer diagnostics refers to the range of screening and testing methods used to detect precancerous changes and identify cervical cancer at an early and more treatable stage. These diagnostic approaches primarily include Pap smear tests, HPV testing, colposcopy, biopsy procedures, and advanced molecular diagnostic techniques. Routine screening helps identify abnormal cervical cells before they develop into invasive cancer, significantly reducing mortality rates. In recent years, the field of cervical cancer diagnostics has evolved with the introduction of liquid-based cytology, biomarker-based assays, and AI-enabled screening technologies, improving accuracy, sensitivity, and accessibility. Increasing awareness programs, government-led screening initiatives, and growing adoption of preventive healthcare practices are further driving the demand for cervical cancer diagnostic solutions worldwide.

Cervical Cancer Diagnostics Market Assessment

Which MedTech key players in the cervical cancer diagnostics market are set to emerge as the trendsetter explore @ Cervical Cancer Diagnostics Market Analysis

Table of Contents

Interested in knowing the cervical cancer diagnostics market share by 2034? Click to get a snapshot of the Cervical Cancer Diagnostics Market Size

Related Reports

Cervical Cancer Market

Cervical Cancer Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key cervical cancer companies, including Roche, AstraZeneca, Precigen, Puma Biotechnology, Iovance Biotherapeutics, Nykode Therapeutics, ISA Pharmaceuticals, Regeneron, Transgene, Daiichi Sankyo, and others.

Cervical Cancer Clinical Trial Analysis

Cervical Cancer Pipeline Insight – 2026 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key cervical cancer companies, including Regeneron Pharmaceuticals, Jiangsu Hengrui Medicine, Akeso Biopharma, Celgene, Henlix Biotech, Zeria, Advaxis, Akeso Biopharma, AnGes, Advenchen Laboratories, Jiangsu Chia Tai Tianqing Pharmaceutical, Valent recombinant vaccine - National Vaccine and Serum Institute, Xiamen Innovax Biotech, Genentech, Celgene, MedImmune, Bristol-Myers Squibb, Ono Pharmaceuticals, InnoMab, BeiGene, Agenus, Ludwig Institute for Cancer Research, EMD Serono, Merck, Apollomics, Immunitor, Genentech, Arcus Biosciences, Guangzhou Gloria Biosciences, Taiho Pharmaceutical, Innovent Biologics, Clovis Oncology, Janssen, GlaxoSmithKline, Iovance Biotherapeutics, and others.

HPV Testing and Pap Test Market

HPV Testing and Pap Test Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key HPV testing and Pap test companies, including F. Hoffmann-La Roche, Hologic Inc., Becton Dickinson, QIAGEN, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Seegene Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Femasys Inc., Arbor Vita Corporation, Quest Diagnostics, LabCorp, Sysmex Corporation, FUJIFILM Holdings, Olympus Corporation, CooperSurgical, Cardinal Health, Nihon Kohden, and others.

HPV Vaccines Market

HPV Vaccines Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key HPV vaccines companies, including GlaxoSmithKline, Xiamen Innovax, Walvax Biotechnology, Merck & Co., Serum Institute of India, and others.

AI in Cancer Diagnostics Market

AI in Cancer Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in cancer diagnostics companies, including iCAD, Inc., ibex-ai, Roche Diagnostics, Kheiron Medical Technologies Limited, MVision AI Inc., Siemens Healthineers AG, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., IBM Corporation, Azra AI, ConcertAI, PathAI, Median Technologies, Paige AI Inc., Therapixel, Flatiron, Freenome Holdings Inc., Onc.AI, Sonrai Analytics, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.